Concepedia

Sha-Mei Liao

SL

Statistics

Publications

19

Citations

4.7K

H-Index

17

Active since

1987

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Massachusetts Institute of Technology

Novartis Institutes for BioMedical Research

Whitehead Institute for Biomedical Research

Sha-Mei Liao is an author at Novartis (Switzerland) specializing in life sciences, molecular biology, and complement system.

ORCID

Publications per year

1987–2022

19

Publications

19

IKKε and TBK1 are essential components of the IRF3 signaling pathway

Katherine A. Fitzgerald, Sarah M. McWhirter, Daniel C. Rowe et al. · Nature Immunology · 2003 · 2.7K citations

, , +6

A kinase–cyclin pair in the RNA polymerase II holoenzyme

Sha-Mei Liao, Jianhua Zhang, D Jeffery et al. · Nature · 1995 · 419 citations

, , +14

Temporal Regulation of RNA Polymerase II by Srb10 and Kin28 Cyclin-Dependent Kinases

Christoph J. Hengartner, Vic E. Myer, Sha-Mei Liao et al. · Molecular Cell · 1998 · 403 citations · Full text

, , +16

IKKε Is Part of a Novel PMA-Inducible IκB Kinase Complex

Robert Peters, Sha-Mei Liao, Tom Maniatis · Molecular Cell · 2000 · 334 citations · Full text

, , +9

Small-molecule factor B inhibitor for the treatment of complement-mediated diseases

Anna Schubart, Karen Anderson, Nello Mainolfi et al. · Proceedings of the National Academy of Sciences · 2019 · 216 citations · Full text

, , +17

1–5 of 19